Overview
Cristina Chelleri practices in Genoa, Italy. Ms. Chelleri is rated as an Advanced expert by MediFind in the treatment of Cafe-Au-Lait Spots. Her top areas of expertise are Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Cafe-Au-Lait Spots, and Legius Syndrome.
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Cafe-Au-Lait Spots.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cafe-Au-Lait SpotsMs. Chelleri isAdvanced. Learn about Cafe-Au-Lait Spots.
- Legius SyndromeMs. Chelleri isAdvanced. Learn about Legius Syndrome.
- NeurofibromatosisMs. Chelleri isAdvanced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Ms. Chelleri isAdvanced. Learn about Neurofibromatosis Type 1 (NF1).
- Experienced
- Aplasia Cutis CongenitaMs. Chelleri isExperienced. Learn about Aplasia Cutis Congenita.
- Clouston SyndromeMs. Chelleri isExperienced. Learn about Clouston Syndrome.
- Ectodermal DysplasiasMs. Chelleri isExperienced. Learn about Ectodermal Dysplasias.
- HemangiomaMs. Chelleri isExperienced. Learn about Hemangioma.
- Hypersensitivity VasculitisMs. Chelleri isExperienced. Learn about Hypersensitivity Vasculitis.
- Moyamoya DiseaseMs. Chelleri isExperienced. Learn about Moyamoya Disease.